About Cx Precision Medicine
Cx Precision Medicine is a private company based in Forth Worth, Texas. It has reported $3,005,287 raised in five offerings on Form D since August 2016. Its chief executive is Danguole Altman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jun 26, 2024 | $0of $4.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Dec 1, 2022 | Dec 13, 2022 | $1,221,233of $3.0M target | 25 | $48,849 | EquityRule 506(b) | Form D ↗ |
| Jul 27, 2021 | Aug 16, 2021 | $934,055of $1.3M target | 12 | $77,838 | Debt, Options, convertible notesRule 506(b) | Form D ↗ |
| Aug 4, 2020 | Aug 19, 2020 | $599,999fully sold | 13 | $46,154 | EquityRule 506(b) | Form D ↗ |
| Jul 12, 2016 | Aug 11, 2016 | $250,000of $1.0M target | 1 | $250K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $3,005,287 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cx Precision Medicine's Form D filed Jun 26, 2024.
DB
Darlene Boudreaux
Executive officer
CC
Cameron Cushman
Director
RF
Robert Ferguson
Director
DA
Danguole Altman
President and CEO, director
EL
Edward Lasater
Director
DK
Donald Keyser
Director
Earlier filings also listed Jeff Keyser (director, last listed Dec 2022) and Frank Gerome (director, ceo and president, last listed Aug 2016).